Shawn Tomasello - 19 Oct 2023 Form 4/A - Amendment Insider Report for Gamida Cell Ltd.

Role
Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
19 Oct 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Oct 2023, 16:39:11 UTC
Date Of Original Report
22 Mar 2023
Previous filing
24 Jul 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMDA Share Option (Right to Buy) Award $0 +17,000 $0.000000 17,000 19 Oct 2023 Ordinary Shares 17,000 $1.32 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Board of Directors of the Issuer on March 20, 2023, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023.
F2 This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

This amendment is being filed solely to correct the transaction date to October 19, 2023 and the expiration date to October 18, 2033.